InvestorsHub Logo
Followers 39
Posts 1624
Boards Moderated 0
Alias Born 04/17/2012

Re: patentminer2013 post# 28

Friday, 02/13/2015 12:53:47 PM

Friday, February 13, 2015 12:53:47 PM

Post# of 360
They are, but it won't happen overnight and nobody should expect it to. Progress over perfection is just fine at this early stage.

If you spend just a few minutes looking at the management and the boards past track record and accomplishments, it's not difficult to see where they may eventually be going with this.

While they have the DenerveX device that is targeted at a very large market, specifically Facet Joint Syndrome which I believe encompasses about 30% of all lower back pain, they also indicate they intend to make strategic acquisitions.

Makes perfect sense because when you look at the fact they have Dr. Andrews and other world renowned physicians on the board of directors, you could envision them providing an almost unlimited amount of opportunities for the company to consider. Because of who their board members are, they may get a first look at some of the best medtech opportunities in existence.

Bottom line, because of who is involved, there should be no shortage of potential "first look" opportunities being funneled in their deal pipeline. At some point, one could envision some of those opportunities, post being thoroughly vetted, coming out the other end in the form of some potential value creation.